Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.24.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jan. 31, 2024
Oct. 31, 2023
Current assets:    
Cash and cash equivalents $ 998 $ 915
Short-term investments 22,800 22,929
Receivables 391 270
Prepaid expenses and other current assets 1,030 1,242
Total current assets 25,219 25,356
Operating lease right-of-use asset 153 166
Total assets 25,372 25,522
Current liabilities:    
Accounts payable 364 206
Accrued expenses 1,242 1,770
Operating lease liability 54 52
Total current liabilities 1,660 2,028
Operating lease liability, non-current 108 123
Total liabilities 1,768 2,151
Commitments and contingencies (Note 10)
Equity:    
Preferred stock, value
Common stock, par value $.01 per share; 100,000,000 shares authorized; 31,754,375 and 31,145,219 shares issued and outstanding as of January 31, 2024 and October 31, 2023, respectively 318 311
Additional paid-in capital 255,738 252,222
Accumulated deficit (231,451) (228,196)
Total shareholders’ equity 24,605 24,337
Noncontrolling interest (Note 2) (1,001) (966)
Total equity 23,604 23,371
Total liabilities and equity 25,372 25,522
Series A Convertible Preferred Stock [Member]    
Equity:    
Preferred stock, value